Background: The evidence base for the diagnosis and management of amyotrophic lateral
sclerosis (ALS) is weak. Objectives: To provide evidence‐based or expert recommendations …

The main aims in the care of individuals with amyotrophic lateral sclerosis (ALS) are to
minimize morbidity and maximize quality of life. Although no cure exists for ALS, supportive …

Pain is a largely neglected symptom in patients with amyotrophic lateral sclerosis (ALS)
although it is reported by most of these patients. It occurs at all stages of the disease and can …

Introduction The use of intrathecal (IT) infusion of analgesic medications to treat patients with
chronic refractory pain has increased since its inception in the 1980s, and the need for …

The care and management of patients with ALS should always be patient focused, with
attention to holistic and emotional aspects of well-being. It is the patient who ultimately …

Background Amyotrophic lateral sclerosis (ALS) is increasingly recognised as a multi-
system disorder, presenting with common and impactful non-motor symptoms, such as …

Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive and fatal
neurodegenerative disease characterized by progressive weakness of voluntary muscles of …

Neurodegenerative diseases are going to increase as the life expectancy is getting longer.
The management of neurodegenerative diseases such as Alzheimer's disease (AD) and …

Patients with amyotrophic lateral sclerosis (ALS) have high symptom burdens, including
pain, fatigue, dyspnea, and sialorrhea, and they must make difficult decisions about the use …

Background: ALS is a progressive neurodegenerative disease with no curative treatment.
Nonmotor symptoms presenting in ALS may cause significant distress, worsen prognosis …